This discovery has been patented and transferred to Inbiomotion, a spin off from the IRB Barcelona and ICREA, founded at the end of…

Kite Pharma, Inc., (NASDAQ: KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment of cancer, today announced…

Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing…

A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent…

News Summary
A team led by Dr. Jaime Modiano, a College of Veterinary Medicine and Masonic Cancer center expert in comparative medicine,…

During a radical surgery to treat a rare bone cancer, surgeons at UC San Diego Health System and Moores Cancer Center removed 50 percent of a patient’s pelvis. Instead…

A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to…

Mother Nature has provided the lizard with a unique ability to regrow body tissue that is damaged or torn - if its tail is pulled off, it grows right back. She has…

Until now, the mode of action of nitrogen-containing bisphosphonate (N-BP) cancer drugs, used to relieve bone pain and to prevent skeletal complications in bone metastasis, has been almost entirely unknown. Researchers…

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have shed new light on Ewing’s sarcoma, an often deadly bone cancer that typically afflicts children and young adults.…

Whites in the United States are nine times more likely than blacks to get Ewing’s sarcoma, a rare cancer of the bone and soft tissue, U.S. researchers said on…

Marines and other military personnel who are wounded in combat as the result of a high-energy trauma, such as a bomb blast, are likely to develop an abnormality known…

The European Commission, which oversees legislation and regulation for the European Union, has approved a therapy for pediatric patients with non-metastatic, resectable osteosarcoma, a type of bone…

A receptor known to be active in bone metastases, but previously unexplored in primary bone tumors, is a potential therapeutic target in osteosarcoma, investigators from The University of Texas M.…

Children who survive bone cancer have a modest risk of developing a second “solid organ” cancer elsewhere in the body later in life, a long-term follow-up study confirms.

Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have…

A recent study shows that pre-operative assessments of patients with breast cancer by physical therapists allow for early diagnosis and successful treatment of lymphedema.

Cryoablation, a procedure most commonly associated with destroying kidney and prostate tumors by freezing them, has been shown to offer durable pain relief of cancer that has spread to bone. The…

Researchers from the Abramson Cancer Center of the University of Pennsylvania announced today that findings from two large, international clinical trials show unprecedented survival for patients with…

Physicians caring for children with cancer should be on the lookout for signs of bone fragility caused by disease and treatment, according to a new report. Published in the April 1,…

Instead of using the usual cancer-fighting modalities, surgery, chemotherapy, or radiation, researchers from a drug development company called Advaxis, have embarked on a novel approach to…

A type of drug used to strengthen bones when cancer has spread there may be linked to a side effect that involves deterioration of the jaw…

Several factors affect bone marrow volume reduction and red blood cell depletion prior to transplantation.

According to recent research published in the journal Bone Marrow Transplantation, “The COBE Spectra is…

Howard Hughes Medical Institute (HHMI) researchers at Stanford University have found that they can increase bone mass in mice by tweaking the shape of a regulatory protein.

HHMI investigator Gerald Crabtree…

Ross Wilkins and Stephen Withrow are doctors working together in the fight against bone cancer. Their goals are the same. Their patients are not.

Dr.…